Oronzo Brunetti
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.
Journal: Expert opinion on drug safety
Published: August 13, 2026
Retraction notice to "The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy" [Biomedicine & Pharmacotherapy 146 (2022) 112588].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 14, 2026
Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-based therapy. A systematic review and meta-analysis of randomized controlled trials.
Journal: Clinical & experimental metastasis
Published: January 15, 2026
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project.
Journal: Clinical and experimental medicine
Published: November 25, 2025
Immunotherapy in biliary tract cancer: effective but not enough?
Journal: Expert review of clinical pharmacology
Published: November 13, 2025
Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.
Journal: Clinical & experimental metastasis
Published: October 24, 2025
Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis.
Journal: Cancer metastasis reviews
Published: October 03, 2025
Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 29, 2025
Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 29, 2025
Last Updated: 09/26/2026